The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Klassen Preston since year 2005.
The trader's CIK number is 1493056.
At the time of this reporting, Klassen Preston is the SVP, Head Global Development of Orexigen Therapeutics, Inc. .
(stock ticker symbol OREX).
See this page for all insider trading activities at Orexigen Therapeutics, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2013-07-25||OREX||Orexigen Therapeutics, Inc.||Sale||71,229||7.16||509,999|
|2013-07-25||OREX||Orexigen Therapeutics, Inc.||Option Ex||71,229||1.66||118,240|
|2013-05-28||OREX||Orexigen Therapeutics, Inc.||Sale||28,771||7.21||207,352|
|2013-05-28||OREX||Orexigen Therapeutics, Inc.||Option Ex||28,771||1.66||47,759|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Klassen Preston (SVP, Head Global Development of Orexigen Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.